About: From SARS to COVID-19: What we have learned about children infected with COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: From SARS to COVID-19: What we have learned about children infected with COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	From SARS to COVID-19: What we have learned about children infected with COVID-19
Creator	Wu, Ying Wu, Jun Li, ; Meng, ; Xie, Xiao-Li Deng, M-J Deng, Xiao-Zhi Peng, X-L Peng, Yong-Gang Shang, Li-Hong Wu, Meng-Jun Xie, Zhou M-Y Xiong, -Jing Xiong, Li-Jing Xiong, Wu Zhou, Meng-Yao
Source	Elsevier; Medline; PMC
abstract	Abstract Coronaviruses, both SARS-CoV and SARS-CoV-2 were firstly appeared in China. They have certain similarities in biological, epidemiological and pathological. To data, the researches have shown that their gene exhibit 79% of identical sequence and the receptor-binding domain structure is also very similar. There have been extensive research performed on SARS, however, the understanding of pathophysiology impact of Corona Virus Disease 2019(COVID-19) is still limited. In the review, we draw upon the lessons learnt from SARS in the epidemiology, clinical characteristics and pathogenesis for further understand the features of COVID-19. By comparing these two diseases, we found, COVID-19 has quicker and wider transmission, obvious family agglomeration, higher morbidity and mortality. Newborns, asymptomatic children and normal chest imaging cases were emerged in COVID-19. Children started with gastrointestinal symptoms may progress to severe condition and newborn whose mother was infected with COVID-19 could have severe complications. The laboratory test data showed, the percentage of neutrophils and the level of LDH is higher, otherwise the number of CD4+ and CD8+T cells is decreased in children's COVID-19 cases. Based on these early observations, as pediatrician, we put forward some thoughts on children's COVID-19 and give some recommendations to contain the disease.
has issue date	2020-05-07(xsd:dateTime)
bibo:doi	10.1016/j.ijid.2020.04.090
bibo:pmid	32389849
has license	els-covid
sha1sum (hex)	d47fd27d9d86a340ef1c1ee2f5987809aea8e172
schema:url	https://doi.org/10.1016/j.ijid.2020.04.090
resource representing a document's title	From SARS to COVID-19: What we have learned about children infected with COVID-19
has PubMed Central identifier	PMC7204709
has PubMed identifier	32389849
schema:publication	International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
resource representing a document's body	covid:d47fd27d9d86a340ef1c1ee2f5987809aea8e172#body_text
is schema:about of	named entity 'COVID-19' named entity 'SARS-COV' named entity 'LEARNED' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'Coronaviruses' named entity 'COVID-19' named entity 'protein' named entity 'China' named entity 'pediatrician' named entity 'Membrane protein' named entity 'pulmonary fibrosis' named entity 'Multidisciplinary team' named entity 'ACE2' named entity 'innate immune' named entity 'epidemiology' named entity 'SARS' named entity 'receptor' named entity 'cough' named entity 'COVID-19' named entity 'COVID-19' named entity 'IFNα' named entity 'adverse reactions' named entity 'NF-kappaB' named entity 'SARS' named entity 'coronavirus' named entity 'white blood cells' named entity 'hormones' named entity 'nuclear factor kappaB' named entity 'T-cell' named entity 'hepatitis' named entity 'Digestive tract' named entity 'SARS' named entity 'kinase' named entity 'SARS-CoV' named entity 'kidney' named entity 'gene' named entity 'antiviral activity' named entity 'immunocompromised' named entity 'IFN' named entity 'lung' named entity 'COVID-19' named entity 'SARS' named entity 'SARS' named entity 'nucleic acid test' named entity 'preterm delivery' named entity 'SARS' named entity 'COVID-19' named entity 'IKK' named entity 'cellular receptors' named entity 'follow-up' named entity 'caregiver' named entity 'therapeutic strategies' named entity 'SARS' named entity 'COVID-19' named entity 'COVID-19' named entity 'cellular immunity' named entity 'hormones' named entity 'protein' named entity 'IFN' named entity 'prognosis' named entity 'COVID-19' named entity 'China' named entity 'COVID-19' named entity 'COVID-19' named entity 'clinical characteristics'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software